258 related articles for article (PubMed ID: 12899007)
1. [Therapy strategy in the treatment of patients with drug-resistant pulmonary tuberculosis].
Ivanova LA; Pavlova MV; Archakova LI
Probl Tuberk Bolezn Legk; 2003; (5):14-6. PubMed ID: 12899007
[TBL] [Abstract][Full Text] [Related]
2. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
3. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
Kononets AS
Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
[TBL] [Abstract][Full Text] [Related]
4. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
6. [Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Pavlova MV; Skvortsova LA; Kondakova MN; Sapozhnikova NV
Probl Tuberk Bolezn Legk; 2004; (1):24-6. PubMed ID: 15137140
[TBL] [Abstract][Full Text] [Related]
7. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
Shaĭkhaev AIa; Naumov VN
Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427
[TBL] [Abstract][Full Text] [Related]
10. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
11. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Gubkina MF; Ershova NG
Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
Frieden TR; Munsiff SS; Ahuja SD
Int J Tuberc Lung Dis; 2007 Jan; 11(1):116. PubMed ID: 17217141
[No Abstract] [Full Text] [Related]
13. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
[TBL] [Abstract][Full Text] [Related]
14. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
Zhukova MP
Probl Tuberk; 1998; (1):14-6. PubMed ID: 9553424
[TBL] [Abstract][Full Text] [Related]
15. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
Moulding TS; Le HQ; Rikleen D; Davidson P
Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
17. Moving forward with evidence and controversies: the challenges of MDR-TB.
Chiang CY; Van Deun A; Caminero JA
Int J Tuberc Lung Dis; 2006 Aug; 10(8):827. PubMed ID: 16898363
[No Abstract] [Full Text] [Related]
18. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
Mishin VIu; Chukanov VI; Vasil'eva IA
Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Ormerod LP
Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
[TBL] [Abstract][Full Text] [Related]
20. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
[Next] [New Search]